Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

GPS-MYC Citations (1)

Originally described in: Application of a MYC degradation screen identifies sensitivity to CDK9 inhibitors in KRAS-mutant pancreatic cancer.
Blake DR, Vaseva AV, Hodge RG, Kline MP, Gilbert TSK, Tyagi V, Huang D, Whiten GC, Larson JE, Wang X, Pearce KH, Herring LE, Graves LM, Frye SV, Emanuele MJ, Cox AD, Der CJ Sci Signal. 2019 Jul 16;12(590). pii: 12/590/eaav7259. doi: 10.1126/scisignal.aav7259.
PubMed Journal

Articles Citing GPS-MYC

Articles
Non-redundant functions of H2A.Z.1 and H2A.Z.2 in chromosome segregation and cell cycle progression. Sales-Gil R, Kommer DC, de Castro IJ, Amin HA, Vinciotti V, Sisu C, Vagnarelli P. EMBO Rep. 2021 Nov 4;22(11):e52061. doi: 10.15252/embr.202052061. Epub 2021 Aug 23. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.